Open AccessFluorescent light energy: Treating rosacea subtypes 1, 2, and 3
Author(s) -
Sannino Mario,
Lodi Giuseppe,
Dethlefsen Markus Wied,
Nisticò Steven Paul,
Cannarozzo Giovanni,
Nielsen Michael Canova Engelbrecht
Publication year - 2018
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.1891
Subject(s) - rosacea , medicine , fluorescence , light energy , dermatology , fluorescent light , pathology , optics , physics , acne
Key Clinical Message Kleresca® biophotonic platform utilizing fluorescent light energy effectively decreased the inflammatory and erythematous reaction common in rosacea subtypes 1, 2, and 3. Kleresca® may be considered as a single treatment for rosacea, targeting multiple features, or combined with invasive methods for an enhanced normalizing and healing profile of the skin.